View
Tube
search
Sign in
Sign up
Subscriptions
VJHemOnc – Video Journal of Hematology & HemOnc
MPN Workshop of the Carolinas 2024
391 views
79 items
Last updated on Oct 7, 2024
public playlist
VJHemOnc – Video Journal of Hematology & HemOnc
2:14
Personalizing the timing of SCT in patients with myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:58
Current barriers to early intervention in myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:29
Changing attitudes to using interferon in pediatric patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
15:45
Updates on the use of ropeginterferon in the treatment of MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:10
The treatment schedule for interferon therapy in patients with PV
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:47
Moving beyond JAK inhibitors: novel targets and pathways being explored for the treatment of MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:31
Important considerations when deciding whether a young patient with MPN should receive cytoreduction
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:06
The importance of early intervention in myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
4:23
Newer treatment options in PV and how the therapeutic landscape is evolving
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:59
Should we move beyond JAK inhibitors in MPNs?
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:15
Cellular therapy modalities being explored for the prevention of post-transplant relapse
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:35
Considering the key benefits of each JAK inhibitor approved for the treatment of MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:31
Young patients with myelofibrosis commonly exhibit inflammatory comorbidities
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:33
A CIBMTR study investigating the effect of donor type on transplantation outcomes in myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:23
Unmet needs and areas of investigation in the treatment of pediatric and AYA patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:24
Prefibrotic myelofibrosis: considerations for diagnosing and managing this entity
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
6:31
A meta-analysis assessing the safety of cytoreductive therapies in younger patients with PV
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:07
Final results of a Phase II study of add-on parsaclisib for pts with MF and suboptimal rux response
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:34
Challenges associated with transplantation in patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
4:15
Accurately assessing treatment response in PV and deciding when to switch therapies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:24
Triple-negative myelofibrosis: disease features and outcomes
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:07
Key takeaways from a panel discussion on interferon in MPNs: considering combination strategies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:05
Stem cell transplant in MPNs: session highlights and key takeaways
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:18
MPNs in pediatric and AYA patients
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:09
Five-year post-approval updates: tagraxofusp in the treatment of BPDCN
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:03
Session highlights: targeting JAK2 and CALR in MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:45
Interferon in PV and ET: unanswered questions
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:45
Deciding which patients with MPNs are suitable candidates for interferon-based therapy
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:00
The potential use of molecular response as a surrogate marker for survival outcomes in MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
3:40
Recommendations for physicians treating PV: selecting between hydroxyurea and interferon
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:48
Promising therapeutic targets in MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:53
Defining suboptimal response to ruxolitinib and the strategy for switching treatments
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:30
Cardiovascular risk factors and pulmonary hypertension in patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:39
Current approaches and recommendations for physicians treating patients with MF and anemia
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:30
Investigating CHIP to address the unanswered questions that remain
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:00
The development of anti-fibrotic agents for treating myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
4:04
Optimizing conditioning regimens for stem cell transplantation in myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:14
Major breakthroughs in the field of BPDCN: combination therapies, managing CNS involvement & more
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:06
Key considerations for physicians when faced with a pregnant patient with MPN
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:06
Origins and treatment options for anemia in myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:41
Targeting BCLxL in MPNs: current perspectives and future outlooks
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:04
Clinical approaches to fertility and pregnancy in patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
7:23
The inaugural MPN Workshop of the Carolinas: the importance of the meeting for the MPN community
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:38
Considerations when selecting between JAK inhibitors for patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:09
Serum albumin as a dynamic treatment-specific surrogate for outcomes in rux-treated pts with MF
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:56
Ongoing and future trials in MPN-AP/BP
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:55
Best use practices for clinicians prescribing interferon to patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:21
Using momelotinib in MF with anemia: dosing and switching from ruxolitinib
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:36
Translational aspects of MPNs: investigating disease biology
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:02
MPN disease biology: JAK2.V617F causes lymphopenia by blocking lymphopoiesis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:59
Investigating JAK2V617F as a therapeutic target in MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:10
BET inhibition for the treatment of myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:46
The recent updates to the NCCN Guidelines for systemic mastocytosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:28
Momelotinib in 2024: how should this agent be used in MF with anemia?
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:46
Selecting patients with MPNs for stem cell transplantation
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:48
Asciminib for the treatment of CML
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:56
The evolving treatment landscape in PV
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:19
Telomerase inhibition as a novel targeted therapy for myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:05
Survival outcomes of patients with MPN-AP/BP treated with current therapies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:21
The potential applications for immunotherapy in MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:27
TP53 mutation in MPNs and investigating LSD1 inhibition in TP53-mutant murine models
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:46
Ruxolitinib in 2024 and beyond: the good, the suboptimal, and the failure
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:25
The current approach to managing patients with prefibrotic PMF
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:34
Are thrombotic risk and progression in ET predictable?
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:30
Results of the RUXOPEG trial: combining ruxolitinib and interferon in patients with myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:00
The role of fedratinib in 2024 and beyond
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:26
The future of JAK inhibition for MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:45
Non-pharmaceutical interventions for patients with MPNs and other hematological malignancies
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:48
An analysis of transfusion-related cost offsets & time burden in pts with MF in the MOMENTUM trial
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:12
Contemporary challenges in polycythemia vera management
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:23
Insights into the management and treatment of accelerated/blast-phase MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:20
Best practices when using tagraxofusp for the treatment of BPDCN
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:07
Advancements in combination strategies with JAK inhibitors for myelofibrosis
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:50
Criteria for the diagnosis of accelerated/blast phase MPN and challenges clinicians may face
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:51
Treatment schedule for ruxolitinib in patients with MPNs and how to assess response
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
0:43
Targeting JAK2 in patients with MPNs
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
2:16
Determining when to switch from hydroxyurea to interferon-based therapy in patients with PV
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:44
The role of interferon in the treatment of accelerated/blast phase MPN
0 views
0
VJHemOnc – Video Journal of Hematology & HemOnc
1:46
How would the approval of luspatercept benefit the treatment landscape in myelofibrosis
0 views
0
